Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

Infection with the SARS-CoV-2 Omicron variant confers weak, short-term protection against reinfection, compared with the much ...

The CD209 expression declined dramatically in various cancer types infected by SARS-CoV-2. Remarkably, CD209 was linked with diverse immune checkpoint genes and infiltrating immune cells. These ...

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

Professor David Ray’s laboratory in the Department of Biological Sciences helped identify genetic components in bats that provide insight into their immune systems.

Many viruses have been linked to bats, as they are known disease carriers. The Ebola, Marburg, Nipah, and Hendra viruses […] ...

Bats are not only very special animals because they are the only flying mammals. They also have a unique defense against viruses, which can be traced back to genetic changes in their immune system.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

It's an unusual winter for respiratory illnesses. The flu is peaking twice: once in early January and again in February.

Diamond and Curiel inserted a gene from SARS-CoV-2, the virus that causes COVID-19, into a harmless virus known as an adenovirus. The adenovirus carries the SARS-CoV-2 protein into the nose, enabling ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...